Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The "Fill Finish Manufacturing Market by Product ((Consumables (PFS (Glass), Plunger Stopper), Vial (RTU, Polymer), Vial Stoppers (RTU), Cartridge, Cell...
-
IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable tolerability across all dose levelsEncouraging early clinical anti-tumor...
-
Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "CAR T-Cell Therapy for Multiple Myeloma Market - A Global and Regional Analysis: Focus on Product, End User, and Region - Analysis and Forecast,...
-
Houston, Texas and Tuebingen, Germany, December 05, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision...
-
Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Cell Therapy Packaging Market Industry Trends and Global Forecasts to 2035, by Type of Therapy Packed, Package Engineering Design, Scale of Operation...
-
Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035: Distribution by Target Antigens, Target Indication, Key Geographies, Sales...
-
Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy CRO Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Cell Therapy, Type of Genetic Modification,...
-
Dublin, Dec. 04, 2025 (GLOBE NEWSWIRE) -- The "Bio/Pharmaceutical Outsourcing Report, October 2025" report has been added to ResearchAndMarkets.com's offering.The Bio/Pharmaceutical Outsourcing...
-
Longeveron Chief Science Officer and Chief Medical Officer selected as speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum (Dec 8-10).
-
Pluristyx launches Organoid COMMONS, uniting 10 industry leaders to set global standards for human-relevant organoids and advance non-animal drug testing.